The Efficacy of PIPAC and Minimally Invasive Radical Resection in High-risk Gastric Cancer Patients.

NCT06295094 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

264

Enrollment

OTHER

Sponsor class

Conditions

Gastric Cancer
Chemotherapy, Adjuvant
Peritoneal Metastases
Minimally Invasive Surgical Procedures

Interventions

DRUG: Cisplatin
DRUG: Doxorubicin

Sponsor

Odense University Hospital

Collaborators

[object Object]